{
  "Q0": "Whole Exome Sequencing (WES) with trio testing",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4.1": "Yes",
  "Q4.2": "ACMG",
  "Q5": "Yes",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q9.1": "Yes",
  "Q10": "No",
  "Q10.1": "Diagnostic",
  "Q11": "Yes",
  "Q12": "Yes",
  "Q13": "Yes",
  "Q14": "Yes",
  "Q14.1": "81415 (for proband) and 81416 (for parents as part of trio)",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "1. Ensure the test is ordered by a clinician with expertise in clinical genetics (in this case, the Pediatric Neurologist qualifies)\n2. Verify genetic counseling was provided about potential risks\n3. Document that previous genetic testing (chromosomal microarray and epilepsy gene panel) was non-diagnostic\n4. Document the clinical presentation (global developmental delay, hypotonia, seizures, cerebellar atrophy) and family history of epilepsy\n5. Indicate the potential for change in management based on test results\n6. Request prior authorization before testing\n7. Use appropriate CPT codes: 81415 for the patient and 81416 for parental samples as part of trio testing\n8. Include relevant ICD-10 codes that document the developmental delay, seizures, and other neurological symptoms",
  "match": false
}